Telephone
61.2.9870.7580
Address
7 Eliza Street Newtown, New South Wales (NSW) 2042
Description
Genetic Signatures Ltd. is a research company, which engages in the identification and commercialization of individual genetic signatures for the diagnosis of infectious diseases. It is also involved in the sale of associated products into the diagnostic and research marketplaces. Its products include the treatment for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. It operates in the following geographical segments: Asia Pacific, Europe, Middle East, and Africa (EMEA), and Americas. The company was founded by Robert J. Birrell, Christopher M. Abbott, and Geoffrey Grigg on February 15, 2001 and is headquartered in Newtown, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.28 - 0.75
Trade Value (12mth)
AU$12,714.00
1 week
1.69%
1 month
-9.09%
YTD
-54.55%
1 year
-60%
All time high
2.87
EPS 3 yr Growth
-524.40%
EBITDA Margin
-100.40%
Operating Cashflow
-$12m
Free Cash Flow Return
-21.90%
ROIC
-35.80%
Interest Coverage
-175.40
Quick Ratio
9.50
Shares on Issue (Fully Dilluted)
227m
HALO Sector
Industrials
Next Company Report Date
27-Aug-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.09
Date | Announcements |
---|---|
28 August 25 |
Change in substantial holding
×
Change in substantial holding |
25 August 25 |
FY25 Appendix 4E and Annual Report
×
FY25 Appendix 4E and Annual Report |
25 August 25 |
FY25 Results Release
×
FY25 Results Release |
25 August 25 |
FY25 Market Update
×
FY25 Market Update |
25 August 25 |
FY25 Appendix 4G and Corporate Governance Statement
×
FY25 Appendix 4G and Corporate Governance Statement |
20 August 25 |
FY25 Results and Investor Webinar Notification
×
FY25 Results and Investor Webinar Notification |
18 August 25 |
Appointment of Chief Technology Officer
×
Appointment of Chief Technology Officer |
22 July 25 |
Strategic Partnership with Tecan and Repado
×
Strategic Partnership with Tecan and Repado |
22 July 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 June 25 |
Notification of cessation of securities - GSS
×
Notification of cessation of securities - GSS |
16 June 25 |
Change in substantial holding
×
Change in substantial holding |
30 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 February 25 |
Notification of cessation of securities - GSS
×
Notification of cessation of securities - GSS |
26 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
26 February 25 |
Positive Momentum For The First Half Result
×
Positive Momentum For The First Half Result |
26 February 25 |
1H FY25 Market Update
×
1H FY25 Market Update |
25 February 25 |
1H FY25 Results and Investor Webinar Notification
×
1H FY25 Results and Investor Webinar Notification |
03 February 25 |
Appendix 3Y - Late Lodgement Notice
×
Appendix 3Y - Late Lodgement Notice |
03 February 25 |
Appointment of Joint Company Secretary
×
Appointment of Joint Company Secretary |
31 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
17 December 24 |
Application for quotation of securities - GSS
×
Application for quotation of securities - GSS |
17 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
09 December 24 |
Notification regarding unquoted securities - GSS
×
Notification regarding unquoted securities - GSS |
27 November 24 |
Notification of cessation of securities - GSS
×
Notification of cessation of securities - GSS |
25 November 24 |
Application for quotation of securities - GSS
×
Application for quotation of securities - GSS |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.